2023 wrapped: Our highlights from a successful year

As 2023 comes to a close, we reflect on another great year at LifeArc filled with, exciting…

LifeArc announces £5 million drug repurposing programme for motor neuron disease

LifeArc is launching new £5m programme to help find new treatments for motor neuron disease (MND). The…

New UK-India research project trialling easy-to-use test to help fight against global threat of antimicrobial resistance

A new UK-India research project, DOSA2, is trialling an easy-to-use test to determine if a urinary tract…

LifeArc opens search for next CEO

For the past several years, LifeArc has been on a journey of transformative change. As we enter…

Seven neurodegeneration research projects receive £14.5m from LifeArc-UKDRI partnership

The first projects to be funded through LifeArc’s £30 million strategic partnership with the UK Dementia Research…

LifeArc-funded documentary highlights pioneering scientific research into new targets for treatment of motor neuron disease

A new documentary has been released which follows a key discovery made by researchers at University College…

LifeArc helps fund new research institute to accelerate the search for a cure for MND

A new research institute to accelerate the search for a cure for motor neuron disease (MND, also…

New £30m initiative to address global threat by accelerating the pace of antimicrobial innovation

Pioneering partnership to drive development of new tests and treatments to tackle deadly antimicrobial resistance, which could…

LifeArc welcomes Stéphane Maikovsky as Interim CEO

LifeArc, the self-funded, not-for-profit medical research organisation today announced the appointment of Stéphane Maikovsky as Interim Chief…